相关实验视频
Updated: May 5, 2026
12:31
In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
22.2K
评估1099种血代谢物对2099种二进制疾病终点的潜在因果影响
Xianyong Yin1, Jack Li2, Debraj Bose2
1Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, China. xianyongyin@njmu.edu.cn.
Nature communications
|March 29, 2025
概括
这项研究使用了门德尔的随机化来研究1099血代谢物如何影响疾病风险. 研究人员确定了282种代谢物和183种疾病之间的潜在因果关系,为代谢疾病途径提供了新的见解.
科学领域:
- 遗传学和新陈代谢学
- 人类健康和疾病研究研究
背景情况:
- 代谢物是疾病风险评估和理解疾病生物学的关键小分子.
- 之前的研究已经强调了代谢物分析在诊断和治疗方面的潜力.
研究的目的:
- 使用大规模遗传方法,系统地推断血代谢物和各种疾病终点之间的潜在因果关系.
- 确定特定的代谢物及其相关疾病,以便进一步研究潜在的生物机制.
主要方法:
- 采用双样本的孟德尔随机化分析.
- 利用了METSIM研究 (6136名芬兰男性) 的数据来测量代谢物和FinnGen研究 (309,154名芬兰人) 的疾病终点.
- 分析了1099个血代谢物与2099个二进制疾病终点对比.
主要成果:
- 确定了282种假定因果关系,将70种代谢物与183种疾病终点联系起来.
- 发现了25种具有跨多种疾病领域潜在因果影响的代谢物,例如影响26种疾病的酸二硫酸.
- 发现了不同代谢途径影响心房风险和特定代谢物的焦虑性人格障碍风险调解的证据.
结论:
- 该研究提供了对代谢物与疾病相关性的综合遗传评估,揭示了许多潜在的因果关系.
- 研究结果表明,特定的代谢物,如酸二硫酸,N-乙-2-氨基诺酸,糖酸硫酸,N-甲基皮皮可酸和N6,N6-二甲基酸在疾病病因学中起着重要作用.
- 这项工作为有针对性的干预和进一步研究代谢途径和疾病预防奠定了基础.
相关概念视频
01:25Mutagenicity and Carcinogenicity
2.0K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
631
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
631
01:29Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129